Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer
Abstract Members of the human epidermal growth factor receptor (HER) family play a significant role in bladder cancer progression and may underlie the development of chemotherapy resistance. Dacomitinib is an irreversible tyrosine kinase inhibitor with structural specificity for the catalytic domain...
主要な著者: | , , , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
BMC
2013-10-01
|
シリーズ: | Molecular Medicine |
主題: | |
オンライン・アクセス: | https://doi.org/10.2119/molmed.2013.00108 |